ODG
Official Disability Guidelines
Source: imantsm/medical_abbreviations
Results for
Direct matches for the acronym you searched.
Official Disability Guidelines
Source: imantsm/medical_abbreviations
Definitions and keywords related to your search.
A Study to Compare the Efficacy and Safety of JCAR017 to Standard of Care in Adult Subjects With High-risk, Transplant-eligible Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphomas
clinical trial
Source: Wikidata
Busulfan, Melphalan and Etoposide as Conditioning for Autologous Transplantation for Non-Hodgkin's Lymphoma (NHL)
clinical trial
Source: Wikidata
Pilot Study of Bortezomib, Bendamustine and Rituximab on Non-Hodgkin's Lymphoma
clinical trial
Source: Wikidata
An Open Label, International, Multi-centre, Phase I/IIa Study of Lenalidomide (Revlimid) and Romidepsin (Istodax) for Relapsed /Refractory Hodgkin Lymphoma, Mature T-cell Lymphoma and Multiple Myeloma. (RId Study)
clinical trial
Source: Wikidata
Brentuximab Vedotin as Alternative to the Autologous Stem Cell Transplantation in Relapsed and Refractory Classical Hodgkin's Lymphoma (BASALT)
clinical trial
Source: Wikidata
A Phase III Randomized, Double Blind, Placebo Controlled Multi-center Study of Panobinostat for Maintenance of Response in Patients With Hodgkin's Lymphoma (HL)
clinical trial
Source: Wikidata
Comparison Study of Rituximab Plus Sargramostim to Rituximab Alone for Relapsed Follicular B-cell Lymphoma, a Form of Non-Hodgkin's Lymphoma
clinical trial
Source: Wikidata
Safety and Efficacy of Revlimid® (Lenalidomide) With Mabthera® (Rituximab) in Non-Hodgkin's Lymphoma
clinical trial
Source: Wikidata
Evaluation of the Relationship Between Anti-PD-1 Exposure and Tumour VOLUME in Patients Treated for Classical HODgkin's Lymphoma.
clinical trial
Source: Wikidata
non-Hodgkin's lymphoma
Source: imantsm/medical_abbreviations
nodular lymphocyte predominant Hodgkin lymphoma
Source: imantsm/medical_abbreviations